Philip Nickson

Insider Reports History

Location
Boston, MA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Nickson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Chief Business & Legal Officer Common Stock 60,845 $923,018 $15.17 05 Jan 2026 Direct
Monte Rosa Therapeutics, Inc. Chief Business & Legal Officer Stock Option (Right to Buy) 126,000 02 Jan 2026 Direct

Insider Reports Filed by Philip Nickson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2026 3 -$47,861 4 Chief Business & Legal Officer 05 Jan 2026, 16:06
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Business & Legal Officer 06 Jan 2025, 16:15
GLUE Monte Rosa Therapeutics, Inc. 03 Jun 2024 1 $0 4 Chief Business & Legal Officer 05 Jun 2024, 16:10
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2024 1 $0 4 General Counsel 04 Jan 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 03 Jan 2023 1 $0 4 General Counsel 04 Jan 2023, 15:31
GLUE Monte Rosa Therapeutics, Inc. 01 Mar 2022 1 $0 4 General Counsel 02 Mar 2022, 17:43
GLUE Monte Rosa Therapeutics, Inc. 01 Mar 2022 0 $0 3 General Counsel 02 Mar 2022, 17:39